Jeff Jacobson

Chief Growth Officer

As Chief Growth Officer, Jeff leads the Marketing, Innovation, Operations and Sales team in North America as well as the Consumer Insights and Data Analytics teams for Cronos Group’s global business. Jeff sets the strategy for our brands and is responsible for leading our global teams to help execute Cronos Group’s vision. Jeff previously served as Cronos Group’s General Manager of Canada and Europe. Before joining Cronos Group, Jeff founded a Toronto based marketing agency and successfully launched and licensed several innovative software products in the mobile industry. As a co-founder of Peace Naturals, Jeff’s expertise and experience in licensing and compliance, new business development, project management and resource management help Cronos Group lead in a variety of markets.

Shannon Buggy

Senior Vice President, Global Head of People

Shannon serves as the SVP, Global Head of People for Cronos Group where she leads HR strategy across the Company’s global operations. Prior to Cronos Group, Shannon was the Senior Vice President of Global Human Resources for Nielsen where she led HR strategy for Nielsen Media. With over 25 years of experience, Shannon has a proven track record of leading and managing global human resources teams and driving excellence in talent acquisition, development, retention, employee relations, compensation, benefits, talent management and labor relations. Shannon holds a certification as a Senior Professional in Human Resources from the HR Certification Institute. She graduated magna cum laude with a Bachelor of Science degree in Human Resources Management from the Pace University, Lubin School of Business.

Terry Doucet

General Counsel and Corporate Secretary

Terry Doucet serves as Cronos Group’s General Counsel and Corporate Secretary. In this capacity, he manages all legal and regulatory affairs at Cronos Group and also serves as the Company’s Corporate Secretary. Prior to joining Cronos, Terry was a corporate lawyer at Davies Ward Phillips & Vineberg LLP in Toronto, where he focused primarily on M&A in large, complex and cross-border transactions across numerous industries, as well as securities, corporate finance and lending transactions. During that time, Terry was also seconded to RBC Capital Markets, where he supported the bank’s derivative trading desks. Terry is an Ontario-qualified lawyer, holding a Juris Doctor from the University of Toronto and a joint honours (first class) Bachelor of Arts degree from McGill University in Montreal.

James Holm

Chief Financial Officer

James Holm serves as Cronos’ Chief Financial Officer. Before joining Cronos, James served as Global Vice President of Finance Transformation at Vertiv and before that he served as Americas Controller from September 2018 to February 2022. Prior to his roles at Vertiv, James served as Worldpay’s Finance Leader, Finance Solutions & Process Transformation Organization from May 2016 to September 2018. Before that, James served at Procter & Gamble in a variety of finance roles from September 2008 to March 2016. James is a Certified Public Accountant and Chartered Global Management Accountant who previously worked as an external auditor for PricewaterhouseCoopers where he worked on various public client engagements, which included working with Fortune 500 companies. He holds a Master of Business Administration (MBA) with a Finance concentration and a Bachelor of Science in Business in Accounting and Finance, both from Wright State University.

Anna Shlimak

Chief Strategy Officer

Anna is Cronos Group’s Chief Strategy Officer and is responsible for managing and directing the organization’s internal and external communications, government affairs, corporate strategy and investor relations. Prior to joining Cronos Group, Anna was the Head of Investor Relations at Quest Partners LLC, a research-driven alternative investment firm. Anna was responsible for business development, investor reporting, marketing and communication initiatives for the fund. Previously, Anna held a range of diverse roles at the New York Stock Exchange in both the New York and London offices. Most recently, Anna was Head of Investor Relations within the Corporate Affairs Group, where she was responsible for managing relationships with investors and sell-side analysts and developing investor communications and reporting. She received a Master of Business Administration (MBA) from Columbia Business School and holds a Bachelor of Science in Economics from The Wharton School at the University of Pennsylvania.

Arye Weigensberg

Head of Research and Development

As Head of Research and Development, Arye is responsible for leading Cronos’ innovation program, where he oversees research and technology functions, and leads scientific efforts to unlock the potential of rare cannabinoids. Before joining Cronos, Arye was the CEO of Altria Israel Ltd, an Altria research and development innovation hub. Arye joined Altria as part of its acquisition of Green Smoke, where he was the Director of Marketing and Brand Management. Prior to Green Smoke, Arye held a variety of roles in brand management and marketing, supporting food brands such as Manischewitz, Lawry’s, Ragu, Knorr and Country Crock. Arye graduated from Concordia University’s John Molson School of Business with a Bachelor of Commerce in Marketing and International Business.

Adam Wagner

SVP, Head of Cronos Israel

Adam Wagner serves as Senior Vice President, Head of Cronos Israel. Adam oversees the business and strategy of Cronos Israel. Before he was appointed as Head of Cronos Israel, he was the VP of Finance at Cronos Israel where he oversaw the regional Israel finance department, including FP&A, controllership, audit, treasury, tax, as well as IT, supply chain and procurement . Before joining Cronos, Adam worked as a Director of Finance at Motus GI, a publicly traded medical device company, where he oversaw the Israel-based finance department. Before that, Adam was a Finance Manager at Medtronic, a publicly traded medical equipment manufacturer, where he oversaw the Israel-based finance department functions. Prior to Medtronic’s acquisition, he was the Corporate Controller for Mazor Robotics, a dual-listed public medical device company. Adam began his career as a Senior Auditor at EY where he managed a team that performed audits for various publicly traded and private companies. Adam also serves as a Finance expert on an advisory board for a wellness and healthcare start-up. Adam is a CPA (Israel) and studied Accounting at Bar-Ilan University. Adam also holds a Bachelor’s Degree in Science of Nutrition and his Master of Science in Genetics and Biochemistry from Tel Aviv University.